According to the Zhitong Finance App, China Resources Pharmaceutical (03320.HK) announced that China Resources Pharmaceutical Group, a subsidiary of the company, achieved total operating revenue of 1,643 billion yuan for the six months ended June 30, 2026, a year-on-year decrease of 50.97%; shareholders of listed companies should account for a net loss of 364 million yuan, and a net profit of 198 million yuan for the same period last year; a basic loss of 0.48 yuan per share.

Zhitongcaijing · 3d ago
According to the Zhitong Finance App, China Resources Pharmaceutical (03320.HK) announced that China Resources Pharmaceutical Group, a subsidiary of the company, achieved total operating revenue of 1,643 billion yuan for the six months ended June 30, 2026, a year-on-year decrease of 50.97%; shareholders of listed companies should account for a net loss of 364 million yuan, and a net profit of 198 million yuan for the same period last year; a basic loss of 0.48 yuan per share.